Derivative exercise or conversion — not an open-market buy.
Loading…
Planned for Sep 10, 2026 · Notice filed Sep 10, 2026
A top manager at Moderna told the SEC they plan to sell $4.69M of Moderna shares around Sep 10, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$5.81M of Moderna
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
